NASDAQ:CMPS Compass Pathways Q3 2026 Earnings Report $11.56 -0.04 (-0.34%) Closing price 10/6/2026 04:00 PM EasternExtended Trading$11.54 -0.02 (-0.14%) As of 08:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Compass Pathways EPS ResultsActual EPSN/AConsensus EPS -$0.36Beat/MissN/AOne Year Ago EPSN/ACompass Pathways Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ACompass Pathways Announcement DetailsQuarterQ3 2026Date11/3/2026TimeBefore Market OpensConference Call DateThursday, November 5, 2026Conference Call Time2:00AM ETConference Call ResourcesEarnings HistoryCompany Profile Compass Pathways Earnings HeadlinesCompass Pathways Announces New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)October 5 at 10:52 PM | marketscreener.comMCompass Pathways : Celebrates Opening of New U.S. Office in Jersey City, New JerseyOctober 5 at 7:46 AM | marketscreener.comMReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 7 at 1:00 AM | Base Camp Trading (Ad)Compass Pathfinder Limited: Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | finanznachrichten.deCompass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2026 | businesswire.comCompass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Stock Has Average Target Price of $23.36 According to BrokeragesOctober 1, 2026 | americanbankingnews.comSee More Compass Pathways Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Compass Pathways? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Compass Pathways and other key companies, straight to your email. Email Address About Compass PathwaysCompass Pathways (NASDAQ:CMPS) plc is a biotechnology company developing psychedelic treatments for mental health conditions. The company’s lead investigational product is COMP360, a proprietary formulation of synthetic psilocybin administered with psychological support in a controlled clinical setting. Compass Pathways has focused primarily on treatment-resistant depression, a condition in which patients do not achieve adequate relief from standard therapies. Its research has also explored the potential use of COMP360 in other serious mental health disorders. COMP360 is an investigational therapy and has not been approved for commercial use by regulatory authorities. Founded in 2016, Compass Pathways is headquartered in London and has conducted clinical development activities in the United States, the United Kingdom and other European countries. The company’s leadership includes Chief Executive Officer Kabir Nath, who joined Compass Pathways after holding senior positions in the biopharmaceutical industry.View Compass Pathways ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Lamb Weston’s Turnaround Is Starting to Look RealAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the StakesInvenTrust’s Sell-Off Opens a Potential Entry PointCuraleaf’s Higher Aurora Bid Raises the Stakes in Cannabis Consolidation3 Low-Rated Stocks Analysts May Be Underestimating Ahead of Q3 EarningsNVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
